Breaking News Instant updates and real-time market news.

ALKS

Alkermes

$57.77

-1.12 (-1.90%)

04:55
11/29/16
11/29
04:55
11/29/16
04:55

Alkermes management to meet with JPMorgan

Meetings to be held in San Francisco/San Mateo on November 28 and in Los Angeles on November 29 hosted by JPMorgan.

  • 29

    Nov

ALKS Alkermes
$57.77

-1.12 (-1.90%)

10/21/16
MSCO
10/21/16
UPGRADE
Target $62
MSCO
Equal Weight
Morgan Stanley ups Alkermes to neutral with $62 target
Morgan Stanley analyst David Risinger upgraded Alkermes to Equal Weight from Underweight after ALKS 5461 succeeded in its third Phase III trial. The analyst raised his price target for the shares to $62 from $45. Risks remain, but an FDA approval can't be ruled out given the unmet need in treatment-resistant depression, Risinger tells investors in a research note. He pegs the approval odds at 50%. Alkermes is trading up 30% to $56.51 in morning trading.
10/24/16
UBSW
10/24/16
NO CHANGE
Target $57
UBSW
Neutral
Alkermes price target raised to $57 from $41 at UBS
UBS analyst Marc Goodman raised his price target for Alkermes to $57 citing the positive Phase III data for ALKS 5461. There is "some chance" of approval based on the current dataset, but the FDA typically requires two positive Phase III studies for approving depression drugs, Goodman tells investors in a research note. The analyst raised the likelihood of approval for ALKS 5461 from 20% to 60%. He keeps a Neutral rating on Alkermes, however, saying the risk/reward is appropriately reflected at current share levels.
11/03/16
LEHM
11/03/16
NO CHANGE
Target $66
LEHM
Overweight
Alkermes Q3 highlighted pipeline advances, says Barclays
Barclays analyst Douglas Tsao believes Alkermes' Q3 earnings report highlighted key advances across its pipeline. The analyst, however, feels that "lumpiness" in Vivitrol gross-to-net over recent quarters "may warrant caution" on the drug's sales trajectory. Tsao still harbors "residual caution" on whether the FDA will accept a single Phase 3 trial for approval of ALKS-5461. Investors though will take comfort in management's reiteration of 2016 guidance, Tsao writes in a post-earnings research note. He keeps an Overweight rating on Alkermes with a $66 price target.
11/11/16
JEFF
11/11/16
NO CHANGE
Target $70
JEFF
Buy
Jefferies says NIH study could be positive for Alkermes' Vivitrol
Jefferies analyst Biren Amin is highlighting a "little known" head-to-head study being conducted at the National Institutes of Health to compare the efficacy of Alkermes' Vivitrol and Indivior's Suboxone. The study enrolled treatment-seeking heroin- and/or prescription opioid-dependent patients admitted into a detox unit, and following a detoxification regimen are randomized to receive Vivitrol or Suboxone treatment for six months, Amin tells investors in a research note. He believes the outcome of the study could have positive implications on Vivitrol's long-term outlook. The analyst does not expect Vivitrol to demonstrate superiority to Suboxone on the primary outcome, but thinks the trial could "illuminate some important differences" and show a trend of improvement for Vivitrol in relapse rate at six months. He points out that Alkermes continues to estimate Vivitrol is currently only capturing 1%-2% market share and sees "significant" room for upside. Data from the study could be seen by year-end 2017 or early 2018, Amin writes. He keeps a Buy rating on Alkermes with a $70 price target.

TODAY'S FREE FLY STORIES

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Conference/Events
KeyBanc to hold a summit »

Emerging Technology…

SAR

Saratoga Investment

$22.22

-0.63 (-2.76%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Hot Stocks
Saratoga Investment raises quarterly dividend to 46c per share »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$4.30

0.3 (7.50%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Earnings
Sangamo reports Q4 EPS (14c), consensus (25c) »

Reports Q4 revenue $8.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 27

    Apr

I

Intelsat

$5.87

1.18 (25.16%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Earnings
Intelsat reports Q4 EPS $5.56 vs. ($38.29) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CAT

Caterpillar

$97.44

1.96 (2.05%)

, ITW

Illinois Tool Works

$131.88

0.2 (0.15%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Conference/Events
Evercore ISI to hold a conference »

Annual Industrials…

CAT

Caterpillar

$97.44

1.96 (2.05%)

ITW

Illinois Tool Works

$131.88

0.2 (0.15%)

URI

United Rentals

$128.21

4.06 (3.27%)

KMT

Kennametal

$37.71

0.08 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 14

    Jun

PRXL

PAREXEL

$66.26

0.32 (0.49%)

, GSK

GlaxoSmithKline

$41.57

0.01 (0.02%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Hot Stocks
PAREXEL names SImon Harford as SVP, CFOG »

PAREXEL International…

PRXL

PAREXEL

$66.26

0.32 (0.49%)

GSK

GlaxoSmithKline

$41.57

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 14

    Mar

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Conference/Events
Credit Suisse to hold a conference »

2017 Global Healthcare…

IONS

Ionis Pharmaceuticals

$46.90

2.31 (5.18%)

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Earnings
Ionis Pharma reports Q4 GAAP EPS 21c, may not compare with consensus (12c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SAR

Saratoga Investment

$22.22

-0.63 (-2.76%)

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Hot Stocks
Saratoga Investment raises quarterly dividend to 46c per share »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$53.22

1.16 (2.23%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Earnings
The Medicines Co. reports Q4 adjusted EPS ($1.19), consensus ($1.43) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FEYE

FireEye

$11.50

0.26 (2.31%)

, PI

Impinj

$29.12

-0.87 (-2.90%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Conference/Events
Pacific Crest to hold a summit »

12th Annual Pacific Crest…

FEYE

FireEye

$11.50

0.26 (2.31%)

PI

Impinj

$29.12

-0.87 (-2.90%)

BL

BlackLine

$29.56

-0.36 (-1.20%)

FB

Facebook

$136.41

0.97 (0.72%)

MB

MINDBODY

$27.05

1.1 (4.24%)

PCTY

Paylocity

$36.41

-0.37 (-1.01%)

AZPN

Aspen Technology

$59.00

0.63 (1.08%)

ECOM

ChannelAdvisor

$10.75

-0.4 (-3.59%)

DATA

Tableau

$53.58

0.32 (0.60%)

CTXS

Citrix

$80.16

-0.02 (-0.02%)

GRPN

Groupon

$4.49

0.02 (0.45%)

CYBR

CyberArk

$50.60

0.07 (0.14%)

PFPT

Proofpoint

$79.35

-0.29 (-0.36%)

WDAY

Workday

$90.19

0.53 (0.59%)

ULTI

Ultimate Software

$199.17

0.81 (0.41%)

AMBR

Amber Road

$7.75

-0.1 (-1.27%)

VEEV

Veeva

$44.14

-0.07 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 10

    Mar

  • 13

    Mar

  • 14

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

SXL

Sunoco Logistics

$25.23

-0.04 (-0.16%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Initiation
Sunoco Logistics initiated  »

Sunoco Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Downgrade
Workday rating change  »

Workday downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

NXST

Nexstar

$70.20

0.45 (0.65%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Earnings
Nexstar reports Q4 EPS 64c including items, consensus $1.38 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 06

    Mar

VRX

Valeant

$16.71

0.53 (3.28%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Hot Stocks
Valeant CEO says 'well poised for turnaround in 2017' »

"Today, we announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 02

    Mar

  • 14

    Mar

ROYT

Pacific Coast Oil

$1.94

0.02 (1.04%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Downgrade
Pacific Coast Oil rating change  »

Pacific Coast Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$0.96

-0.016 (-1.63%)

07:06
02/28/17
02/28
07:06
02/28/17
07:06
Hot Stocks
22nd Century receives feedback from FDA regarding MRTP application »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYLD

NRG Yield

$17.55

-0.19 (-1.07%)

07:05
02/28/17
02/28
07:05
02/28/17
07:05
Hot Stocks
NRG Yield reconfirms 2017 outlook »

NRG Yield is reconfirming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TA

TravelCenters

$7.45

0.15 (2.05%)

07:05
02/28/17
02/28
07:05
02/28/17
07:05
Earnings
TravelCenters reports Q4 EPS (17c), consensus (6c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

METC

Ramaco Resources

$10.89

-0.03 (-0.27%)

07:05
02/28/17
02/28
07:05
02/28/17
07:05
Initiation
Ramaco Resources initiated  »

Ramaco Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$41.82

-0.54 (-1.27%)

07:05
02/28/17
02/28
07:05
02/28/17
07:05
Hot Stocks
AT&T, Bridge Alliance enter collaboration »

AT&T and members of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

NYLD

NRG Yield

$17.55

-0.19 (-1.07%)

07:04
02/28/17
02/28
07:04
02/28/17
07:04
Earnings
NRG Yield reports Q4 net loss ($126M), adjusted EBITDA $207M »

The company said the Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

VRX

Valeant

$16.71

0.53 (3.28%)

07:04
02/28/17
02/28
07:04
02/28/17
07:04
Earnings
Valeant sees FY17 revenue $8.9B-$9.10B, consensus $8.97B »

Sees FY17 Adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 02

    Mar

  • 14

    Mar

SFTBF

SoftBank

$74.95

-0.93 (-1.23%)

, I

Intelsat

$5.87

1.18 (25.16%)

07:03
02/28/17
02/28
07:03
02/28/17
07:03
Hot Stocks
Breaking Hot Stocks news story on SoftBank, Intelsat »

SoftBank to capitalize…

SFTBF

SoftBank

$74.95

-0.93 (-1.23%)

I

Intelsat

$5.87

1.18 (25.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

I

Intelsat

$5.87

1.18 (25.16%)

, SFTBF

SoftBank

$74.95

-0.93 (-1.23%)

07:03
02/28/17
02/28
07:03
02/28/17
07:03
Hot Stocks
Intelsat, OneWeb announce conditional combination agreement »

Intelsat (I) and OneWeb…

I

Intelsat

$5.87

1.18 (25.16%)

SFTBF

SoftBank

$74.95

-0.93 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.